Mave Health develops a $495 transcranial direct current stimulation (tDCS) headset that delivers 1–2 mA currents and weighs roughly 100 grams, intended for daily ~20-minute sessions to boost attention, mood and reduce stress. The device pairs with an app that tracks long-term trends in mood, focus and stress, integrates other health data such as heart rate variability (HRV), and uses baseline and follow-up self-reported assessments. The company ran a private beta with more than 500 users in 2024–2025, during which eight in ten users reported a 60% increase in productivity and 75% reported stress reduction within two months from baseline. Mave Health has conducted four observational studies across about 200 participants that are currently under academic review and aims to publish results this year. Founded in 2023 by Dhawal Jain, Jai Sharma and Aman Kumar and based in San Francisco, the startup positions the headset as a lifestyle device rather than a regulated medical product. The company plans to begin shipping its first batch to customers in the U.S. and India in April 2026.

Total raised

$3M

Funding rounds

2

Latest round

Seed

Latest activity

Mar 2026